Assignee
GENTIUM S R L
IT·7 granted patents·8 pending applications·19 citations·filing 2015–2025
Top patents by PatentIndex Score
15 records- 0195US11746348B2Euglobulin-based method for determining the biological activity of defibrotideGENTIUM S R L·Filed 2021·Granted Sep 5, 2023·3 cites·19 claims
- 0295US11085043B2Euglobulin-based method for determining the biological activity of defibrotideGENTIUM S R L·Filed 2020·Granted Aug 10, 2021·5 cites·19 claims
- 0394US11236328B2Euglobulin-based method for determining the biological activity of defibrotideGENTIUM S R L·Filed 2021·Granted Feb 1, 2022·4 cites·19 claims
- 0490US2025075206A1Euglobulin-based method for determining the biological activity of defibrotideGENTIUM S R L·Filed 2024·Application pending·0 cites
- 0588US10393731B2Cellular-based method for determining the biological activity of defibrotideGENTIUM S R L·Filed 2015·Granted Aug 27, 2019·7 cites·20 claims
- 0686US2023357762A1Euglobulin-based method for determining the biological activity of defibrotideGENTIUM S R L·Filed 2023·Application pending·0 cites
- 0782US12534722B2Euglobulin-based method for determining the biological activity of defibrotideGENTIUM S R L·Filed 2025·Granted Jan 27, 2026·0 cites·15 claims
- 0882US12529052B2Euglobulin-based method for determining the biological activity of defibrotideGENTIUM S R L·Filed 2025·Granted Jan 20, 2026·0 cites·10 claims
- 0976US12584903B2Cellular-based method for determining the potency of defibrotideGENTIUM S R L·Filed 2023·Granted Mar 24, 2026·0 cites·21 claims
- 1071US2021052622A1Defibrotide for use in prophylaxis and/or treatment of graft versus host disease (gvhd)GENTIUM S R L·Filed 2020·Application pending·0 cites
- 1170US2018334672A1Euglobulin-based method for determining the biological activity of defibrotideGENTIUM S R L·Filed 2017·Application pending·0 cites
- 1265US2023084937A1Methods for treating patients having sinusoidal obstruction syndromeGENTIUM S R L·Filed 2022·Application pending·0 cites
- 1364US2017304349A1Defibrotide for use in prophylaxis and/or treatment of graft versus host disease (gvhd)GENTIUM S R L·Filed 2017·Application pending·0 cites
- 1463US2020057051A1Cellular-based method for determining the biological activity of defibrotideGENTIUM S R L·Filed 2019·Application pending·0 cites
- 1561US2019328765A1Methods for treating patients having sinusoidal obstruction syndromeGENTIUM S R L·Filed 2019·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when GENTIUM S R L files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →